BioNexus Gene Lab Corp (NASDAQ:BGLC) currently has a daily average trading volume of 149.04K but it saw 1263796 shares traded in last market. With a market cap of 8.99M USD, the company’s current market price of $0.51 came rising about 2.81 while comparing to the previous closing price of $0.50. In past 52 weeks, the stock remained buoying in the range of price level as high as $6.80 and as low as $0.31.
Taking a look at 20-day trading activity of BioNexus Gene Lab Corp (BGLC) gives us an average price of $0.4912, while its current price level is -92.51% below from 52-week high level whereas it is 64.19% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.5023 while that of 200 days or SMA-200 reads an average of $0.5825. A closer look into the stock’s movement over the week reveals that its volatility is standing at 14.51% during that period while stretching the period over a month that decreases to 8.47%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 52.79 which implies that the stock is in neutral territory.
Over the week, BGLC’s stock price is moving -3.96% down while it is 7.09% when we observe its performance for the past one month. Year-to-date it is -3.96% down and over the past year, the stock is showing a downside performance of -90.49%.
Currently, BioNexus Gene Lab Corp’s total number of outstanding shares is 17.67M. Company’s return on investment (ROI) stands at -28.24% and return on equity (ROE) at -33.50%. Stock’s beta reads 1.85. Stock has a price to book (P/B) ratio of 0.96 while price to sale or P/S ratio amounts to 0.92. Its return on asset (ROA) is -27.53% on average.
